Szarvas T - Search Results

1

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.

Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, Hollósi P, Nyirády P, Szarvas T. Módos O, et al. Among authors: szarvas t. Oncotarget. 2016 Jun 28;7(26):39293-39301. doi: 10.18632/oncotarget.9828. Oncotarget. 2016. PMID: 27283768 Free PMC article.

2

The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.

Füle T, Máthé M, Suba Z, Csapó Z, Szarvas T, Tátrai P, Paku S, Kovalszky I. Füle T, et al. Among authors: szarvas t. Virology. 2006 May 10;348(2):289-96. doi: 10.1016/j.virol.2005.12.043. Epub 2006 Feb 24. Virology. 2006. PMID: 16499942 Free article.

3

Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.

Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Szarvas T, et al. Oncol Rep. 2007 Aug;18(2):405-9. Oncol Rep. 2007. PMID: 17611663

4

Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.

Riesz P, Lotz G, Páska C, Szendrôi A, Majoros A, Németh Z, Törzsök P, Szarvas T, Kovalszky I, Schaff Z, Romics I, Kiss A. Riesz P, et al. Among authors: szarvas t. Pathol Oncol Res. 2007;13(3):187-94. doi: 10.1007/BF02893498. Epub 2007 Oct 7. Pathol Oncol Res. 2007. PMID: 17922047 Free article.

5

Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Pathol Oncol Res. 2009 Jun;15(2):193-201. doi: 10.1007/s12253-008-9107-z. Epub 2008 Sep 20. Pathol Oncol Res. 2009. PMID: 18807212 Free article.

6

[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].

vom Dorp F, Börgermann C, Schenck M, Becker M, Rose A, Szarvas T, Rübben H. vom Dorp F, et al. Among authors: szarvas t. Urologe A. 2009 Jan;48(1):51-3. doi: 10.1007/s00120-008-1760-z. Urologe A. 2009. PMID: 19048222 Review. German.

7

Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.

Szarvas T, Jäger T, Tötsch M, vom Dorp F, Kempkensteffen C, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Clin Cancer Res. 2008 Dec 15;14(24):8253-62. doi: 10.1158/1078-0432.CCR-08-0677. Clin Cancer Res. 2008. PMID: 19088043

8

[Urine-based markers of angiogenesis in bladder cancer].

Becker M, Tilki D, Szarvas T, Rübben H, Ergün S. Becker M, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1. Urologe A. 2009. PMID: 19557465 Review. German.

9

[Urine-based cytological diagnosis against the background of the new histopathological classification].

Tschirdewahn S, Boergermann C, Becker M, Szarvas T, Rübben H, vom Dorp F. Tschirdewahn S, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):615-8. doi: 10.1007/s00120-009-1990-8. Urologe A. 2009. PMID: 19557466 German.

10

[The value of urinary cytology in the diagnosis of high grade urothelial tumors].

Niedworok C, Rembrink V, Hakenberg OW, Börgermann C, Rossi R, Schneider T, Becker M, Szarvas T, von Ostau C, Swoboda A, Rübben H, vom Dorp F. Niedworok C, et al. Among authors: szarvas t. Urologe A. 2009 Sep;48(9):1018, 1020-2, 1024. doi: 10.1007/s00120-009-2077-2. Urologe A. 2009. PMID: 19697005 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page